ALGENEX S.L logo

ALGENEX S.L

Tres Cantospharmaceuticals

About

Algenex S.L. is a biotechnology company based in Tres Cantos, Madrid, Spain, founded in 2005. The company specializes in baculovirus-based technologies for producing recombinant biologics. Algenex has developed proprietary platforms, TopBac® and CrisBio®, which enhance the scalability and efficiency of protein production in insect cells. They have successfully produced over 200 molecules, including vaccines, diagnostic reagents, enzymes, and growth factors, through collaborations with various public and private partners. Algenex focuses on large-scale protein production for both human and animal healthcare. Their offerings include the development of vaccines, diagnostic kits, and immunopotentiators. The company has achieved significant milestones, such as the EMA validation of CrisBio® for vaccine manufacturing and the launch of a new vaccine production facility. Algenex is recognized for its contributions to veterinary health and is expanding into human health, emphasizing rapid response capabilities for pandemics and equitable vaccine access.